InsidersTradesSigma
Discover the complete record of transactions filed by Ives Jeffrey L., Director. Director active across 1 companies, notably Cara Therapeutics, Inc.. Aggregated, 5 disclosures have been recorded. Total volume traded: €229k. The latest transaction was disclosed on 2 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Ives Jeffrey L. serves as a Board Member at Cara Therapeutics, Inc. He brings expertise in corporate governance and strategy. His role involves overseeing company policies and contributing to strategic decision-making. With his experience, he helps guide the company's direction towards sustainable growth objectives.